Sanofi SNY and Regeneron’s REGN Dupixent (dupilumab), an injectable monoclonal antibody that blocks IL-4/IL-13 signaling, is an approved therapy for multiple allergic and atopic diseases.

Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...

Dupilumab: A monoclonal antibody that inhibits interleukin-4 and interleukin-13 signaling, used to treat various allergic conditions. This Nature Research Intelligence Topic summary is one of ...

Following receipt of dupilumab for 24 weeks, desensitization to peanut exposure in most children/adolescents with peanut allergy was not achieved, according to study results. Image: Adobe Stock ...